SGLT2 inhibitors reduce weight and fat mass in older adults with T2DM, with smaller muscle mass decline
SGLT2 diabetes drugs reduce weight and fat in older adults, with small muscle loss
A meta-analysis of 8 RCTs in 541 older adults with Type 2 diabetes found SGLT2 inhibitors significantly reduced body weight (SMD=-0.85) and …
SGLT2 diabetes drugs help older adults lose weight and fat, but they also cause a small, measurable drop in muscle mass that doctors should …
SGLT2 inhibitors associated with lower mortality in ATTR-CM patients receiving disease-modifying therapy
Could a common diabetes drug help people with a serious heart condition live longer?
A meta-analysis of 7 observational studies including 7,283 patients with ATTR cardiomyopathy found SGLT2 inhibitor use was associated with l…
A common diabetes drug linked to lower death risk and fewer heart attacks for people with a serious heart condition called transthyretin amy…